Orthobiologics Market Revenue Share, Growth Factors, Trends, Analysis & Forecast, 2025

Posted by sneha j on July 27th, 2022

Orthobiologics are substances that orthopedic surgeons utilize to help injuries heal more quickly. These products are made from substances that are naturally found in human body. These are used to improve the healing of broken bones and injured muscles, tendons, and ligaments.

The key factors that drive the growth of the global orthobiologics market are increase demand for advanced treatment and rise in prevalence of osteoarthritis, degenerative arthritis, spinal injuries, and soft tissue injuries majorly drive the growth of the market. Further, rise in obesity rate, growth in awareness among the patients, and increase in geriatric population supports the market growth. However, high cost of procedures and stringent regulatory approval process restrict the growth of this market. Advancements in implant technologies and growth in demand for biological solutions create opportunities for market growth.

Download Sample Report: https://www.alliedmarketresearch.com/request-sample/845

The global orthobiologics market is segmented based on product, application, type, end user, and region. Based on product, the market is classified into demineralized bone matrix (DBM), allograft, bone morphogenetic protein (BMP), viscosupplementation products, synthetic bone substitutes, and others. Viscosupplementation products is the largest and the fastest growing segment. This is due to its application for treatment of knee pain associated with osteoarthritis. Increase in geriatric population, rise in prevalence of osteoarthritis, and growth in lifestyle-induced disorders, such as obesity, drive the adoption of viscosupplement products.

Based on type, the market is categorized into knee, ankle, hip, wrist & shoulder, spine, and others. The knee segment held largest share in the market in 2017; this is due to rise in number of aged patients undergoing knee replacement procedures. Spine is the fastest growing segment due to rise in number of sports related injuries to the spine.

Based on application, the market is categorized into application such as osteoarthritis & degenerative arthritis, spinal fusion, fracture recovery, soft tissue injuries, maxillofacial, and dental applications. Osteoarthritis & degenerative arthritis is the largest segment due to increase in prevalence of these conditions. Spinal fusion was the fastest growing segment in 2017 owing to the benefits offered by orthobiologics in the treatment.

Based on end user, the market is categorized into hospitals & ambulatory centers, research & academic institute, and dental clinics. The hospitals & ambulatory centers segment held largest share in the market in 2017 and is the fastest growing segment as these facilities are fully equipped for performing the surgeries and have the skilled professionals to carry out the procedures.

Based on region, the market is studied across North America (U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and rest of Europe), Asia-Pacific (China, Japan, Australia, India, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).

Get Detail Report https://www.alliedmarketresearch.com/orthobiologics-market

Like it? Share it!

sneha j

About the Author

sneha j
Joined: July 12th, 2022
Articles Posted: 104

More by this author